top of page

JAMA Report Finds Use of MAT for OUD Increased Among Medicaid Recipients

A recent study reported in the Journal of the American Medical Association (JAMA) revealed that the use of medication for the treatment of OUD increased among Medicaid enrollees from 2014 to 2018. In the 11 States included in this study, MAT for OUD increased from 47.8% in 2014 to 57.1% in 2018. Researchers noted Medicaid expansion accounted for some of these increases and, while this study did reveal an improvement in access to medications for OUD treatment, researchers also noted significant variability between States as well as gaps in treatment. To read the study, click here.

6 views0 comments

Recent Posts

See All

SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.

bottom of page